What are the guidelines for colonoscopy screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colonoscopy Screening Guidelines

For average-risk adults, begin colorectal cancer screening at age 45 years with colonoscopy every 10 years or annual fecal immunochemical testing (FIT), and continue screening through age 75. 1, 2

Starting Age for Screening

Average-Risk Individuals

  • Begin screening at age 45 years for all average-risk adults, based on rising colorectal cancer incidence in younger populations and similar rates of advanced neoplasia in 45-49 year-olds compared to those aged 50-54 1, 2, 3
  • The American Cancer Society issued this as a qualified recommendation in 2018, representing the most current guidance 4
  • Some guidelines still recommend age 50 as the starting point, but the trend toward age 45 reflects emerging evidence of increasing early-onset disease 4, 5

African Americans

  • Start screening at age 45 years (or age 40 per some guidelines) due to higher disease burden and earlier age of onset in this population 4, 6

High-Risk Individuals with Family History

  • Begin colonoscopy at age 40 years OR 10 years before the youngest affected relative's diagnosis, whichever comes first, if you have: 4, 1, 2, 5
    • A first-degree relative with colorectal cancer or advanced adenoma diagnosed before age 60, OR
    • Two or more first-degree relatives with colorectal cancer at any age
  • Repeat colonoscopy every 5 years in these higher-risk patients 4, 2, 5
  • For a single first-degree relative diagnosed at age 60 or older, begin average-risk screening at age 40 4, 5

Recommended Screening Tests

Tier 1 (Preferred) Options

The highest quality evidence supports two cornerstone strategies:

  • Colonoscopy every 10 years - preferred by multiple societies including the American College of Gastroenterology 4, 1, 6, 2
  • Annual FIT (fecal immunochemical test) - equally effective when adherence is maintained 4, 1, 2, 5

These two tests should be offered first in any screening program. If colonoscopy is declined, FIT should be the immediate alternative. 5

Tier 2 (Alternative) Options

These are appropriate but have disadvantages relative to Tier 1 tests:

  • Multitarget stool DNA test (FIT-DNA) every 3 years 1, 2, 7
  • CT colonography every 5 years 4, 1, 5
  • Flexible sigmoidoscopy every 5-10 years (can be combined with annual FIT) 4, 1, 5
  • High-sensitivity guaiac-based fecal occult blood test (HSgFOBT) annually 1, 7

Not Recommended

  • Septin9 serum assay should NOT be used for screening due to insufficient evidence 5

When to Stop Screening

Age-Based Stopping Points

  • Discontinue screening at age 75 for patients who are up-to-date with prior negative screening tests, particularly if they had a negative colonoscopy 1, 2, 5
  • For ages 76-85, individualize decisions based on: 4, 1
    • Overall health status and comorbidities
    • Life expectancy (screening only beneficial if >10 years expected survival)
    • Prior screening history (those never screened may still benefit)
  • Discourage screening beyond age 85 as harms outweigh benefits 4, 1, 2

Life Expectancy Considerations

  • Stop screening when life expectancy falls below 10 years, regardless of chronological age 6, 2, 5

Critical Follow-Up Requirements

All positive non-colonoscopy screening tests MUST be followed by timely diagnostic colonoscopy - failure to do this negates the entire benefit of screening. 1, 2, 5

Quality Metrics for Colonoscopy

Colonoscopy quality directly impacts screening effectiveness. Physicians must measure and report: 2

  • Cecal intubation rate >90% in screening populations 2
  • Withdrawal time ≥6 minutes 2
  • Adenoma detection rate ≥25% in men and ≥15% in women over age 50 2
  • Appropriate follow-up intervals based on findings 1
  • Complication rates 1, 2

Common Pitfalls to Avoid

  • Inadequate bowel preparation significantly reduces colonoscopy effectiveness; if preparation is suboptimal, repeat within 1 year or consider alternative modality 4, 1
  • Failing to follow up positive stool tests with colonoscopy completely eliminates screening benefit 1, 2
  • Continuing screening too long in patients with limited life expectancy exposes them to unnecessary procedural risks 1, 2
  • Stopping screening too early in healthy 75-year-olds with life expectancy >10 years misses prevention opportunities 1, 5
  • Variable colonoscopy quality between providers can dramatically impact detection rates - choose high-quality endoscopists 1, 2

Special Populations Requiring Different Approaches

Inflammatory Bowel Disease

  • Begin colonoscopy 8-10 years after symptom onset in ulcerative colitis or Crohn's colitis 8
  • Repeat every 1-3 years depending on disease activity and other risk factors 8

Hereditary Syndromes

  • Lynch syndrome (HNPCC): Begin colonoscopy at age 20-25 years, repeat every 1-2 years 4, 8
  • Familial adenomatous polyposis: Begin screening at age 10-12 years with annual sigmoidoscopy or colonoscopy 4, 8
  • Peutz-Jeghers syndrome: Begin colonoscopy at age 8 years, repeat at age 18, then every 3 years if normal 8

References

Guideline

Colorectal Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Colon Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Colorectal Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Optimal Strategies for Colorectal Cancer Screening.

Current treatment options in oncology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.